
AMCP opposes government regulation of drug pricing because of the potential for unintended consequences and supports the elimination of barriers to competition to bring down the high cost of prescription drugs.
Stay up-to-date on recent legislative and regulatory developments and actions that AMCP has taken on behalf of members that impact managed care pharmacy professionals. AMCP's position statements are regularly reviewed and updated by the AMCP Board of Directors.